Form 4 for TMO Thermo Fisher Scientific
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-28 · accession 0000097745-26-000053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-02 | 2026-02-28 | TMO | CASPER MARC N | COB, CEO, Dir | F - Tax | $521.11 | -4,685 | 125.1K | -4% | -$2.44M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-28 | F | D | 1,211.17 | $521.11 | 123,925.36 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-28 | F | D | 3,473.76 | $521.11 | 125,136.53 | D | — | — |